East Brunswick, NJ, United States of America

Yashwant M Deo

This inventor holds 21 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Medarex Inc., Celldex Therapeutics Limited, Celldex Research Corporation. Active years: 1998-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yashwant M Deo. Retrieved from https://idiyas.com/inventor/yashwant-m-deo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 52.4



Average Co-Inventor Count = 3.9

ph-index = 15

Forward Citations = 1,359(Granted Patents)


Location History:

  • Audubon, PA (US) (1998 - 2004)
  • Annandale, NJ (US) (2006)
  • East Brunswick, NJ (US) (2008 - 2015)

Company Filing History:


Years Active: 1998-2015

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Monoclonal Antibodies
Dendritic Cells
CTLA-4
CD30
Molecular Conjugates
Fc Receptor
Therapeutic Compounds
Binding Agents
Multispecific Compounds
Therapeutic Applications
21 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yashwant M Deo

Introduction

Yashwant M Deo, located in East Brunswick, NJ, is a distinguished inventor known for his significant contributions in the realm of biotechnology. With a remarkable portfolio of 21 patents, Deo has made strides in developing innovative therapeutic solutions.

Latest Patents

Among Deo's latest patents are groundbreaking discoveries in the field of immunology. One notable invention is the series of isolated human monoclonal antibodies that specifically target dendritic cells. This patent encompasses bispecifics, immunotoxins, and antigen conjugates featuring these antibodies or their binding portions. His innovations include the use of non-human transgenic animals, such as transgenic mice, capable of producing various isotypes of human monoclonal antibodies through mechanisms like V-D-J recombination and isotype switching. Furthermore, Deo’s patent on human CTLA-4 antibodies presents novel treatments for various human diseases and conditions, illustrating the potential applications of his discoveries in therapeutic and diagnostic settings.

Career Highlights

Throughout his career, Yashwant M Deo has been associated with reputable companies including Medarex Inc. and Celldex Therapeutics Limited. At these organizations, he played an instrumental role in advancing biopharmaceutical innovations that cater to unmet medical needs.

Collaborations

Deo has collaborated with various esteemed professionals in his field, notably Tibor P Keler and Robert F Graziano. These partnerships have fostered the exchange of knowledge and expertise, contributing to the success of his projects and the furtherance of cutting-edge research.

Conclusion

Yashwant M Deo's journey as an inventor continues to inspire and drive innovation in biotechnology. His extensive patent portfolio reflects not only his creativity and ingenuity but also his commitment to improving human health through science. As he continues to explore new frontiers in research, the impact of his work will certainly resonate in the medical community and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…